Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mini

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapyS Nobili, D Checcacci, F Filippelli, et al.
Journal of Inorganic Biochemistry|May 1, 1997
Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm)P Calamai, S Carotti, A Guerri, et al.
Biochemical Pharmacology|September 15, 1987
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cellsE Mini, T Mazzei, M Coronnello, et al.
Cancer Research|January 1, 1985
Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cellsE Mini, S Srimatkandada, W D Medina, et al.
Investigational New Drugs|January 1, 1985
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancerP Periti, G R della Cuna, F Pannuti, et al.
The Journal of Physiology|December 1, 1995
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cellsA Arcangeli, L Bianchi, A Becchetti, et al.
Anti-Cancer Drugs|July 18, 2000
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotidesM Morganti, M Coronnello, B Caciagli, et al.
Oncology Research|November 8, 2001
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivityM Coronnello, G Marcon, S Carotti, et al.
Scientific Reports|June 26, 2026
Deep learning for wetland vegetation mapping in the southeastern United States: evaluating site-specific accuracy and classification challengesObioma C Ogwo, Hamdi A Zurqani, Douglas C Osborne, et al.
Anti-Cancer Drug Design|February 25, 1998
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatinP Calamai, S Carotti, A Guerri, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapyS Nobili, D Checcacci, F Filippelli, et al.
Journal of Inorganic Biochemistry|May 1, 1997
Biological properties of two gold(III) complexes: AuCl3(Hpm) and AuCl2(pm)P Calamai, S Carotti, A Guerri, et al.
Biochemical Pharmacology|September 15, 1987
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cellsE Mini, T Mazzei, M Coronnello, et al.
Cancer Research|January 1, 1985
Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cellsE Mini, S Srimatkandada, W D Medina, et al.
Investigational New Drugs|January 1, 1985
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancerP Periti, G R della Cuna, F Pannuti, et al.
The Journal of Physiology|December 1, 1995
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cellsA Arcangeli, L Bianchi, A Becchetti, et al.
Anti-Cancer Drugs|July 18, 2000
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotidesM Morganti, M Coronnello, B Caciagli, et al.
Oncology Research|November 8, 2001
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivityM Coronnello, G Marcon, S Carotti, et al.
Scientific Reports|June 26, 2026
Deep learning for wetland vegetation mapping in the southeastern United States: evaluating site-specific accuracy and classification challengesObioma C Ogwo, Hamdi A Zurqani, Douglas C Osborne, et al.
Anti-Cancer Drug Design|February 25, 1998
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatinP Calamai, S Carotti, A Guerri, et al.
Pageof 10